A new analysis of global pharmacovigilance data indicates that while reports of psychiatric distress are common among users ...

A panel of experts advising the U.S. Food and Drug Administration (FDA) voted against adopting MDMA as a treatment for post-traumatic stress disorder (PTSD) on Tuesday. Members of the FDA’s ...

The FDA is poised to approve the notorious party drug as a therapy. Here’s what it means, and where similar drugs stand in the US. MIT Technology Review’s What’s Next series looks across industries, ...

For a while, MDMA looked poised to make history. After decades of advocacy from impassioned supporters, the party drug best known as ecstasy emerged as the frontrunner to be the first psychedelic ...

A key FDA advisory committee rejected the use of a psychedelic drug to help patients struggling with PTSD, questioning its safety and effectiveness. The FDA must now decide whether it will follow suit ...

A week after an FDA committee declined to support an midomafetamine (MDMA) treatment for post-traumatic stress disorder (PTSD), Lykos Therapeutics is looking to dispel some concerns about the therapy ...